Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Glaxosmithkline Pharmaceuticals Ltd. Share Price
Day's Range
Day's Range
Low
₹2,423.50
High
₹2,490.00
Price Summary
| Previous Close | ₹2,481.30 |
|---|---|
| Day's Range | ₹2,423.50 - ₹2,490.00 |
| Open | ₹2,423.50 |
| 52 Week Range | ₹2,217.60 - ₹3,515.70 |
| Volume | 1,29,747 |
| Market Cap | ₹0.04 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3,204.68 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 2.18 |
| Price/Earning (TTM) | 41.13 |
| TTM EPS (₹) | 60.27 |
| P/E Ratio | 52.55 |
| Book Value(₹) | 20.96 |
| PAT Margin (%) | 22.50 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 67.64 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 9494.2 | 34072.5 |
| Expenses | N/A | N/A |
| PBT | 3081.0 | 8090.4 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 2298.8 | 5846.9 |
About Glaxosmithkline Pharmaceuticals Ltd.
| Founded | 1924 |
|---|---|
| Managing Director | Bhushan Akshikar |
| NSE Symbol | GLAXO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,134.01 | 1,831.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,77,883.86 | 6,681.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,47,526.68 | 4,351.60 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,12,696.26 | 7,820.45 | 6,677.50 - 6,677.50 |
| Lupin Ltd. | 1,12,463.67 | 2,460.50 | 1,836.80 - 1,836.80 |
| Cipla Ltd. | 1,10,088.66 | 1,361.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,09,072.97 | 1,307.00 | 1,138.50 - 1,138.50 |
| Max Healthcare Institute Ltd. | 98,793.98 | 1,015.10 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 98,063.24 | 2,375.40 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 94,596.06 | 940.10 | 835.50 - 835.50 |
No Records Found
Latest News
GlaxoSmithKline Pharmaceuticals informs about disclosure
In terms of Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the Board of Directors have jointly authorized the following personnel of the Company, for the purpose of determining the materiality of any event or transaction for the purpose of making disclosures to the Stock Exchange. 1. Bhushan Akshikar Managing Director. Email: - bhushan.2.akshikar@gsk.com. 2. Ronojit Biswas Whole- time Director & Chief Financial Officer: - Email:- ronojit.b.biswas@gsk.com. 3. Ajay Nadkarni Company Secretary Email: ajay.a.nadkarni@gsk.com. 4. Amit Pandey Head of Legal Email:- amit.g.pandey@gsk.com.
The above information is a part of company’s filings submitted to BSE.
GlaxoSmithKline Pharmaceuticals informs about change in senior managerial personnel
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), GlaxoSmithKline Pharmaceuticals has informed that the Vinay Subramanian, Commercial Head – Oncology would be part of leadership team effective 20th April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed.
GlaxoSmithKline Pharmaceuticals informs about updates
GlaxoSmithKline Pharmaceuticals informs about outcome of board meeting
GlaxoSmithKline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals has informed that the Company has received an Order dated 21st January 2026 from Madhya Pradesh GST authorities, disallowing certain GST credits in Madhya Pradesh State. The relevant details to be is disclosed is enclosed.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Glaxosmithkline Pharmaceuticals Ltd. is ₹2,481.30 as of 2026-05-07.
The market capitalisation of Glaxosmithkline Pharmaceuticals Ltd. is ₹41,994.91 as of 2026-05-07.
The 1-year return of Glaxosmithkline Pharmaceuticals Ltd. is 0.00% as of 2026-05-07.
The P/E ratio of Glaxosmithkline Pharmaceuticals Ltd. is 52.55 as of 2026-05-08.
The 52-week high and low of Glaxosmithkline Pharmaceuticals Ltd. are ₹3,515.70 and ₹2,217.60, respectively, as of 2026-05-07.
People Also Ask
GlaxoSmithKline Pharmaceuticals Ltd. forms partnerships by collaborating with medical professionals and government health agencies to promote mass immunisation and disease awareness. The company ensures a robust supply chain to deliver life-saving medicines consistently to hospitals and regional clinics.
GlaxoSmithKline Pharmaceuticals Ltd. offers an important range of prescription medicines and preventative vaccines. The company focuses heavily on anti-infectives, dermatology, pediatric vaccines, and general medicines, supplying highly trusted pharmaceutical brands to the Indian healthcare system.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
